Back to results
US 2026/0240992 A1Published application
Anti-rsv monoclonal antibody formulation
AssigneeMedImmune, LLC
InventorsBrian LOBO, Deborah GOLDBERG
Life of this patent
Estimating the term…
Abstract
The present invention provides a formulation comprising: (i) an anti-RSV monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater and the ionic excipient is present at a concentration of between 50 and 150 mM and the formulation has a pH of about 5.5 to about 7.5.
Claims30
A formulation comprising:
- i. an anti-RSV monoclonal antibody;
- and
- ii. an ionic excipient;
- wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater and the ionic excipient is present at a concentration of about 50 to about 150 mM,
- wherein the monoclonal antibody has a pI of about pH 5.5 to about pH 7.5;
- and
- wherein the formulation has a pH of about 5.5 to about 7.5.
4 more elements
(canceled)
(canceled)
-7. (canceled)
(canceled)
(canceled)
-28. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.